Israel Active

Researchers at Israel’s Ben-Gurion University and at Israel’s Weizmann Institute have discovered a new subset of T helper cells - CD4-Eomes cells – are prominent in people well over 100 years old. these T helper cells act to clean out the system of senescence cells that accelerate aging.

Detailed article about the magnetic field helmet invented by Yaron Segal and commercialized by Israel’s BrainQ (see previously). It now has the CE mark – which means it’s safe to be sold and used across Europe – and has been approved by Israel’s ministry of health.

Israel spends less than most OECD countries on health, yet it has one of the lowest levels of infant mortality, heart disease mortality, and preventable deaths. Israel’s average life expectancy is 83.8 years – almost a year more than in 2023 and the fourth highest in the OECD.

Downton Abbey creator Lord Julian Fellowes was successfully treated for essential tremor at St. Mary’s Hospital, London with the incisionless focused ultrasound therapy from Israel’s Insightec. He had lost the ability to write by hand due to involuntary shaking.

The new US policy announcement making In Vitro Fertilization (IVF) more accessible is good news for Israel, which has been at the forefront of IVF treatment for decades. It opens up a massive opportunity for medical technology companies, particularly in Israel’s vibrant fem-tech scene.

A new study from the Hebrew University of Jerusalem shows that the auditory cortex, one of the brain’s main sound-processing centers, changes how it operates when we focus on a task. It synchronizes its activity to the rhythm of the task rather than merely reacting to sounds.

Israel’s Immunai has used its immune system AI mapping platform to discover a novel therapeutic target for inflammatory bowel disease (IBD). Immunai has partnered with AstraZeneca who will develop the therapy, which if successful will earn Immunai up to $85 million.

Israel’s CAPS Medical (see previously) has received FDA Breakthrough Device Designation for its its PlasmaSure™ System to treat low- to intermediate-risk non-muscle invasive bladder cancer (NMIBC).

I missed this discovery in May by scientists at Israel’s Weizmann Institute. They identified that ROR-gamma-T cells trigger a chain reaction of four types of immune cells, which stop the body’s attacking cells (CD8 cells) from responding to food proteins.

Israel’s CorNeat Vision (see previously) has implanted its KPro artificial cornea to restore perfect vision in a patient blinded by corneal scarring from the Shingles virus. In addition, the eye, once deformed by shingles, now looks remarkably natural and healthy.